The combination of intravascular and percutaneous high-dose-rate brachytherapy may be a promising palliative approach for advanced HCC with macrovascular invasion into the right atrium.
Hypothesis-generating for combined brachytherapy in advanced HCC with atrial invasion; does not support routine use pending prospective trials.
The presented report describes a case of a Hepatocellular carcinoma (HCC) tumor thrombus (TT) infiltrating the inferior vena cava (IVC) and the right atrium (RA) in a 66-year old male patient who initially presented with TT related symptoms. CT-guided high-dose-rate brachytherapy (HDRBT) was performed for both, the intraparenchymal primary and the TT. A marked improvement of the tumor-related symptoms and shrinkage of the tumor mass were achieved six months after treatment initiation. The combination of intravascular and percutaneous HDRBT demonstrating a promising approach to palliate tumor-related symptoms in advanced HCC with macrovascular invasion.
No takes yet. Share an insight, caveat, or question.
Fleckenstein et al. (2021) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: